Journey medical corporation

Major-Pharmaceuticals

DERM


275 Middlefield Road
Menlo Park , CA 94025

Executive/
Director

Price

  • Last Close
  • $ 4.25
    $ +0.2 4.94 %
    Jan 3, 2025
  • 52-Week High/Low
  • $7.96 - $2.11
  • YTD
  • 0%

  • Trading Volume
  • 1,001
  • Market Cap Full
  • $ 75.7M
  • Shares Outstanding
  • 17.8M
    Mar 31, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 12.5% -71.3% 88.5% -5% - -10.2% -18.2% -35.9% 8.8% -
Q2 -14.6% 20.1% -29.3% 4% 87.5% -22.6% 1.3% 56% - -
Q3 -7.3% 24% -33.5% 8% 87.5% -34.2% 72.3% -6.4% - -
Q4 1.7% -38.3% 134.8% - -46.2% -22% 109.5% -30.8% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 8.8% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -12%-8%-74%106%26%-71%-64%200%-32%9%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 - -1.42 -1.49 - - - -0.57
Q2 - -0.57 -0.33 - - - -0.46
Q3 - -1.58 -1.06 - - - 0.80
Q4 - -1.7 - - -4.32 -0.61 -
A 0 -5.3 -2.9 0.5 -4.3 -1.7 -0.23

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 9.2 17.3 17.8
Jun - 9.2 17.5 -
Sep 9.1 9.2 17.6 -
Dec 9.1 10.2 17.5 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - 0.1
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - 0.9
Debt – Equity Ratio - - - - -34.7
Interest Coverage -14 -3.9 2.7 5 -
Equity multiplier - - - - -1